OncoSenX is a late stage pre-clinical cancer company headquartered in Seattle, Washington. OncoSenX targets solid tumors based on transcriptional activity using a unique lipid nanoparticle and plasmid DNA.
The next generation in cancer therapies will be more targeted with less side effects. At OncoSenX we believe the battle against cancer should be fought with genetic information. Our treatment delivers a simple program that induces apoptosis in cancerous cells. Our approach is a less invasive, more precise intervention for this complex and devastating disease.
Company Details
- Employees
- 9
- Address
- 800 5th Ave, Seattle,washington 98104,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- oncosenx.com
- HQ
- Seattle, Washington
Oncosenx Questions
Oncosenx's website is oncosenx.com
Oncosenx's LinkedIn profile is https://www.linkedin.com/company/oncosenx
Oncosenx has
9 employees.
View email and phone details for 9
employees at Oncosenx.
Oncosenx's industry is
Biotechnology Research
Oncosenx's top competitors are
Immusoft,
Brainchild Bio,
Nanostics Inc.,
Entos Pharmaceuticals,
Hdt Bio,
Legend Biotech,
Aegis Life, Inc.,
Mozart Therapeutics, Inc.,
Lumen Bioscience,
Oisin Biotechnologies.
Oncosenx's categories are Biotechnology Research
